Prognostic significance of platelet-to-albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A retrospective study of 858 cases

Despite evidence supporting the high correlation of the novel platelet-to-albumin ratio (PAR) with survival in diverse malignancies, its prognostic relevance in nasopharyngeal carcinoma (NPC) remains underexplored. This study aimed to examine the link between PAR and overall survival (OS) in NPC and to establish a predictive model based on this biomarker.